Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07MSJ
|
|||
| Former ID |
DNC004662
|
|||
| Drug Name |
1-(5-Pyridin-2-yl-oxazol-2-yl)-octadec-9-yn-1-one
|
|||
| Synonyms |
CHEMBL174397; SCHEMBL3202757; 1-(5-Pyridin-2-yl-oxazol-2-yl)-octadec-9-yn-1-one
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H36N2O2
|
|||
| Canonical SMILES |
CCCCCCCCC#CCCCCCCCC(=O)C1=NC=C(O1)C2=CC=CC=N2
|
|||
| InChI |
1S/C26H36N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-24(29)26-28-22-25(30-26)23-19-17-18-21-27-23/h17-19,21-22H,2-8,11-16,20H2,1H3
|
|||
| InChIKey |
PFSWYEYBMPLGTD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as a... J Med Chem. 2005 Mar 24;48(6):1849-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.